• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » MobileODT raises $7m for portable cervical cancer detection device

MobileODT raises $7m for portable cervical cancer detection device

July 6, 2017 By Sarah Faulkner

MobileODTMobileODT said today that it raised $6.8 million in a Series B financing round. OrbiMed Advisors led the financing and was joined by a previous investor, Tristel.

To date, the Israeli cancer diagnostic company has raised more than $13 million.

MobileODT’s device, EVA, is a cheap, portable device that uses an imaging system to detect cervical cancer. The colposcope is designed particularly for populations without access to traditional diagnostic methods.

The company already sells its product in the U.S. and is looking to expand into other markets.

“We are excited to accelerate our growth through this financing round led by some of the world’s best strategic and healthcare investors,” chairman & CEO Ariel Beery said in prepared remarks. “This financing together with the recent launch of the third generation mobile colposcope, the FDA cleared EVA System, will enable us to fulfill our promise to reach every patient.”

In connection with the funding, OrbiMed Advisors venture partner Dr. Ron Ginor plans to join the MobileODT’s board of directors.

“MobileODT is at the forefront of a critical race to bring contemporary healthcare to the billions of people who do not have ready access to expert physicians,” Ginor said. “I believe their platform will impact and improve lives across the globe”.

“There are 5.8 billion people worldwide who have no access to healthcare that we would consider adequate. But, a great number of this population has access to a mobile phone. This is a new frontier in medicine that is developing rapidly,” Tristel CEO Paul Swinney added. “MobileODT is at the forefront of this exciting development in healthcare, and has had the foresight to acknowledge the importance of disinfection. We take great comfort in investing alongside the leading healthcare investor, Orbimed Advisors.”

Filed Under: Diagnostics, Funding Roundup, Gynecological, Oncology Tagged With: mobileodt

More recent news

  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe
  • Ceryx Medical raises $15M to support bioelectronic pacemaker

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy